Advertisement

Topics

LenioBio and Fraunhofer Institute to develop protein expression platform

08:00 EDT 15 Aug 2018 | BioPharma-Reporter

LenioBio and Fraunhofer Institute IME have entered a licensing agreement, allowing LenioBio to commercialize technology into a protein expression platform.

Original Article: LenioBio and Fraunhofer Institute to develop protein expression platform

NEXT ARTICLE

More From BioPortfolio on "LenioBio and Fraunhofer Institute to develop protein expression platform"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...